Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$819M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$550M |
| 3 |
Boston Scientific
BSX
|
+$303M |
| 4 |
ExxonMobil
XOM
|
+$291M |
| 5 |
Advanced Micro Devices
AMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$513M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Target
TGT
|
+$379M |
| 4 |
Eli Lilly
LLY
|
+$351M |
| 5 |
EOG Resources
EOG
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 11.16% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
OR Royalties Inc
OR
$5.59B
| $191K | ﹤0.01% |
18,951
+6
| +0% | +$72 |
|
3627
UWM Holdings
UWMC
$614M
| $190K | ﹤0.01% |
52,909
+6,616
| +14% | +$25.4K |
|
|
BNY
3628
DELISTED
BlackRock New York Municipal Income Trust
BNY
| $189K | ﹤0.01% |
17,108
+10
| +0.1% | +$113 |
|
|
RDFN
3629
DELISTED
Redfin
RDFN
| $188K | ﹤0.01% |
22,842
-19,379
| -46% | -$222K |
|
|
ACB
3630
Aurora Cannabis
ACB
$172M
| $187K | ﹤0.01% |
14,159
-1,447
| -9% | -$36.2K |
|
|
PMX
3631
DELISTED
PIMCO Municipal Income Fund III
PMX
| $185K | ﹤0.01% |
20,095
-663
| -3% | -$6.24K |
|
3632
Telefônica Brasil
VIV
$20.7B
| $185K | ﹤0.01% |
19,322
+719
| +4% | +$7.39K |
|
3633
Cemex
CX
$17B
| $184K | ﹤0.01% |
46,897
+8,801
| +23% | +$37.7K |
|
|
IGI
3634
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94M
| $180K | ﹤0.01% |
10,655
-590
| -5% | -$10.3K |
|
3635
Smith & Wesson
SWBI
$651M
| $178K | ﹤0.01% |
13,549
-30,241
| -69% | -$438K |
|
3636
TAL Education Group
TAL
$6.91B
| $178K | ﹤0.01% |
37,324
-1,966
| -5% | -$7.51K |
|
|
JOAN
3637
DELISTED
JOANN, Inc. Common Stock
JOAN
| $175K | ﹤0.01% |
+22,551
| New | +$207K |
|
3638
Anavex Life Sciences
AVXL
$256M
| $174K | ﹤0.01% |
17,405
+300
| +2% | +$2.84K |
|
3639
BridgeBio Pharma
BBIO
$15.8B
| $174K | ﹤0.01% |
+19,195
| New | +$161K |
|
|
JMIA
3640
Jumia Technologies
JMIA
$744M
| $174K | ﹤0.01% |
28,610
+3,798
| +15% | +$27.8K |
|
3641
Nkarta
NKTX
$147M
| $171K | ﹤0.01% |
+13,870
| New | +$182K |
|
|
TDF
3642
Templeton Dragon Fund
TDF
$271M
| $166K | ﹤0.01% |
11,630
-7,261
| -38% | -$92K |
|
3643
Ocular Therapeutix
OCUL
$1.8B
| $164K | ﹤0.01% |
40,858
+21,990
| +117% | +$83.1K |
|
3644
Ambev
ABEV
$47.9B
| $163K | ﹤0.01% |
65,249
-1,394
| -2% | -$3.98K |
|
3645
Escalade
ESCA
$274M
| $163K | ﹤0.01% |
12,612
+839
| +7% | +$11K |
|
3646
Nomura Holdings
NMR
$28.3B
| $163K | ﹤0.01% |
45,458
-13,095
| -22% | -$50K |
|
|
LAZR
3647
DELISTED
Luminar Technologies
LAZR
| $162K | ﹤0.01% |
1,818
-86
| -5% | -$13.7K |
|
|
PMF
3648
DELISTED
PIMCO Municipal Income Fund
PMF
| $162K | ﹤0.01% |
14,055
+318
| +2% | +$3.53K |
|
|
TSP
3649
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $162K | ﹤0.01% |
+22,423
| New | +$204K |
|
|
FTCH
3650
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $160K | ﹤0.01% |
22,388
+1,600
| +8% | +$16.4K |
|
Similar funds
Ameriprise's Q2 2022 Portfolio in Review
As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
- Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
- Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
- Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
- Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
- Ameriprise opened 137 new positions and closed 191 in Q2 2022.
- Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.